Infusion Brands International, Inc.

Infusion Brands International, Inc.

INBI
Infusion Brands International, Inc.US flagOther OTC
0.00
USD
- -
- -
18,146.00Market Cap
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2010 Y
2011 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.07
0.67
0.19
0.05
0.1
0.08
Basic EPS, GAAP
-0.04
- -
-0.01
-2.64
-4.89
-0.39
-0.71
-0.1
-0.1
-0.16
Free Cash Flow per Basic Share
- -
- -
-0.01
-0.17
-0.08
-0.62
-0.04
-0.04
-0.04
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.04
-0.04
-0.04
-2.28
-4.74
-3.21
-0.38
-0.37
-0.37
-0.39
Tangible Book Value per Share
- -
-0.01
- -
-2.19
-2.55
-2.83
-0.04
-0.06
-0.14
-0.27
Basic Weighted Avg Shares
5
5
6
11
14
15
138
159
178
181
Sales/Revenue/Turnover
- -
- -
- -
- -
1
10
26
8
18
14
Operating Margin (%)
- -
- -
- -
-148,119.73
-448.11
-39.14
-32.85
-155.84
-37.81
-38.84
Depreciation Expense
- -
- -
- -
1
1
1
2
1
- -
- -
Net Income, GAAP
- -
- -
- -
-24
-15
-3
-31
-16
-7
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-920,484.96
-1,591.74
-26.83
-118.95
-192.81
-38.19
-40.76
Working Capital
- -
- -
- -
- -
-2
- -
5
2
1
-4
LT Debt
- -
- -
- -
- -
- -
2
2
2
2
2
Total Equity
- -
- -
- -
-22
-35
-40
-3
-7
-18
-41
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
30.87
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'12
Jun'12
Sep'12
ST Debt
- -
- -
2
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
7
7
7
Shares Outstanding
181
181
181
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Mar'12
Jun'12
Sep'12
Total Current Assets
4
4
6
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
2
2
2
Total Current Liabilities
5
6
9
Payables & Accruals
5
5
6
ST Debt
- -
- -
2
Deferred Revenue
- -
1
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
62.29%
171.2%
Free Cash Flow
- -
137.5%
9.16%
Net Income, GAAP
- -
169.83%
-56.79%
Sales/Revenue/Turnover
- -
7,536.59%
118.18%
Total Cash Common Dividend
- -
- -
-83.72%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
2
1
5
4
8
2011
4
5
2
6
18
2012
2
3
3
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
-0.06
- -
0.09
- -
-0.1
2011
-0.02
-0.02
-0.03
- -
-0.1
2012
-0.04
-0.04
-0.05
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Robert Leasure
Full Time Employees
47
Sector
Consumer Cyclical
Industry
Specialty Retail
Address
14375 Myerlake Circle Clearwater FL United States of America 33760
IPO Date
Aug 16, 2006
Business
Infusion Brands International, Inc. (INBI) operates as a holding company focused on acquiring, developing, and scaling consumer brands in the health, wellness, and lifestyle sectors. The company offers a portfolio of branded products including nutritional supplements, functional beverages, personal care items, and wellness accessories, distributed through e-commerce platforms, retail partners, and direct-to-consumer channels. Its core services encompass brand management, product formulation, supply chain optimization, and digital marketing strategies tailored for growth-stage consumer goods companies. Headquartered in Miami, Florida, and founded in 2021, Infusion Brands International serves target markets in North America and Europe, with expanding operations into Asia-Pacific regions. The company targets health-conscious consumers, retailers, and distributors seeking innovative, science-backed wellness solutions across its business segments of nutraceuticals, beauty, and functional foods. In the last two years, Infusion Brands International completed a significant funding round in early 2025, raising $25 million in Series B financing led by strategic investors to fuel acquisitions and product launches. It recently acquired WellnessForge Brands in Q3 2025, integrating premium adaptogen-based supplements into its portfolio, and announced a strategic partnership with a leading e-commerce platform to enhance global distribution. These moves mark a major expansion phase, including the launch of a new line of AI-personalized nutrition products and a reorganization to streamline international operations.